UNSPSC 51113202: Benzodepa

This classification denotes an ethylenimine compound with the molecular formula C12H16N3O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q30T24YM3F, chemically known as carbamic acid, (bis(1-aziridinyl)phosphinyl)-, phenylmethyl ester but more generally known as benzodepa, which bears US NIH Compound Identifier 16111. European Medicines Agency schedules Benzodepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05758MIG.

UNSPSC 51113202 Benzodepa is a Commodity code addressing pharmaceutical products, specifically chemotherapy agents, that state and local health agencies procure through their pharmacy benefit programs and direct-contracting initiatives. The Texas Health and Human Services Commission's recent Request for Information on Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions (RFI HHS0017013, posted April 3, 2026) signals active state interest in establishing direct relationships between pharmacy benefit programs and pharmaceutical manufacturers to manage prescription fulfillment and cost. State health and human services agencies are the primary issuing bodies under this code, seeking to bypass traditional pharmacy benefit managers, group purchasing organizations, and wholesalers in favor of negotiated net pricing models and outcomes-based agreements with manufacturers or authorized direct-contracting vendors.

Texas represents the documented geographic center of recent activity under this code. The state's HHS Commission is in preliminary market-intelligence gathering to inform future formal solicitations around direct-to-manufacturer prescription programs. The April 2026 RFI does not specify budget amounts, timelines, or formal evaluation criteria—it functions as an exploratory procurement mechanism to assess vendor capacity for direct contracting with self-insured employers and health plans, experience with negotiated pricing without rebates, and capability to implement value-based agreements. Responses to the RFI will shape the state's design of subsequent RFPs and procurement specifications. No formal competitive solicitation or award activity under the code is currently posted; the RFI represents the visible current signal for this commodity.